Cargando…
Structure-based discovery and bio-evaluation of a cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one as a phosphodiesterase 10A inhibitor
Phosphodiesterase10A (PDE10A) is a potential therapeutic target for the treatment of several neurodegenerative disorders. Thus, extensive efforts of medicinal chemists have been directed toward developing potent PDE10A inhibitors with minimal side effects. However, PDE10A inhibitors are not approved...
Autores principales: | Al-Nema, Mayasah, Gaurav, Anand, Lee, Vannajan Sanghiran, Gunasekaran, Baskaran, Lee, Ming Tatt, Okechukwu, Patrick, Nimmanpipug, Piyarat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979230/ https://www.ncbi.nlm.nih.gov/pubmed/35425186 http://dx.doi.org/10.1039/d1ra07649c |
Ejemplares similares
-
Evaluation of the acute oral toxicity and antipsychotic activity of a dual inhibitor of PDE1B and PDE10A in rat model of schizophrenia
por: Al-Nema, Mayasah, et al.
Publicado: (2022) -
Docking based screening and molecular dynamics simulations to identify potential selective PDE4B inhibitor
por: Al-Nema, Mayasah, et al.
Publicado: (2020) -
Coarse-Grained Modelling and Temperature Effect on the Morphology of PS-b-PI Copolymer
por: Chiangraeng, Natthiti, et al.
Publicado: (2019) -
Estimation of Inhibitory Effect against Tyrosinase Activity through Homology Modeling and Molecular Docking
por: Nokinsee, Daungkamon, et al.
Publicado: (2015) -
3D-QSAR modelling dataset of bioflavonoids for predicting the potential modulatory effect on P-glycoprotein activity
por: Wongrattanakamon, Pathomwat, et al.
Publicado: (2016)